ZCZhao Chen

Zhao Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhao Chen has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Successful treatment of allergic bronchopulmonary aspergillosis using a combination of oral voriconazole and the bronchoscopic instillation of amphotericin B

    by HuaMan Wu, MaoLiang Tian, Zhao Chen, XiaoYu He, Yang Zeng, Lun Wang, ZhiPing Deng

    Rationale: Allergic bronchopulmonary aspergillosis (ABPA) is a complex pulmonary disease that results from hypersensitivity reactions triggered in response to A fumigatus . To date, there have been few reports of ABPA patients exhibiting elevated serum carcinoembryonic antigen levels. Moreover, while systemic antifungal treatment often results in substantial side effects when administered to ABPA patients, there has been little published regarding bronchoscopic amphotericin B instillation as an alternative treatment strategy. Patient concerns: We describe an ABPA patient who was repeatedly misdiagnosed with lung cancer. This 60-year-old woman complained of a 5-year history of a recurrent cough with whitish viscous sputum that had recurred and worsened within the 2 days before presentation. This woman had visited hospitals many times during this interval, and pulmonary computed tomography scans had revealed an occupying lesion in the left upper lobe of her lung. This, coupled with her elevated serum carcinoembryonic antigen levels and other lung cancer markers, led to the misdiagnosis of lung cancer. Diagnoses: As we found that she also exhibited elevated serum IgE and circulating eosinophil counts, and Aspergillus was detected through rapid on-site evaluation, we sent a further blood sample for fungal antigen-specific antibody testing. This approach revealed markedly elevated levels of A fumigatus -specific IgE, Aspergillus -specific IgG and IgM, leading to the confirmation of an ABPA diagnosis. Interventions: The patient was administered inhaled budesonide together with antifungal therapy consisting of oral voriconazole and bronchoscopic amphotericin B instillation. She was additionally provided empiric antibiotic treatment to alleviate her cough and reduce phlegm production. Outcomes: Her symptoms and the associated lung lesion improved significantly. Lessons: Bronchoscopic amphotericin B instillation represents a safe and effective approach to treating ABPA, providing a means of increasing local drug concentrations while minimizing the potential for systemic adverse reactions.

  • Open Access

    Elevated C‐Reactive Protein–Albumin–Lymphocyte Index Is Associated With Reduced Mortality in Chronic Inflammatory Airway Diseases: A Population‐Based Observational Study

    by Yuting Fan, Zhao Chen, Mingshan Xue, Wenqiang Li, Youli Wen, Baoqing Sun, Zhiping Deng

    Background: The C‐reactive protein–albumin–lymphocyte (CALLY) index, a novel composite marker derived from lymphocyte count, serum albumin, and C‐reactive protein (CRP) levels, is commonly used to assess nutritional and inflammatory status. However, existing studies have not clarified the association between the CALLY index and prognosis in patients with chronic inflammatory airway diseases (CIADs). This study aims to elucidate the relationship between the CALLY index and the risks of all‐cause and cardiovascular mortality among CIAD patients in the United States. Methods: This investigation included 4128 patients with CIAD from the National Health and Nutrition Examination Survey (NHANES, 1999–2010). The CALLY index was measured only at baseline. We employed weighted Cox proportional hazards regression models to assess the association between the CALLY index and risks of all‐cause and cardiovascular mortality across three progressively adjusted models. To evaluate potential nonlinear dose–response relationships, we applied restricted cubic spline (RCS) models. Additionally, subgroup analyses and sensitivity analyses were conducted to verify the robustness of our findings. Results: Multivariable‐adjusted Model 3 demonstrated that, compared with the lowest quartile, the highest CALLY index quartile showed a significant inverse association with both all‐cause and cardiovascular mortality, with corresponding HRs of 0.36 (95% CI: 0.27–0.47) and 0.33 (95% CI: 0.21–0.51), respectively (both p < 0.05). Conclusions: The CALLY index showed a significant inverse association with all‐cause and cardiovascular mortality among U.S. adults with CIAD, suggesting its potential value as a prognostic tool for risk stratification in this group.

  • Open Access

    Association of an antioxidant-rich diet with all-cause and cardiovascular mortality in hypertensive patients: A prospective study

    by Zhao Chen, Qian Huang, Wenqiang Li, Peng Zhou, Qian He, Zhiping Deng

    This study investigates the relationship between the composite dietary antioxidant index (CDAI) and the risk of all-cause and cardiovascular mortality in individuals with hypertension, aiming to provide dietary recommendations to reduce mortality. Data were sourced from the National Health and Nutrition Examination Survey (NHANES) database. The best cut-off for CDAI in relation to survival outcomes was determined using the maximally selected rank statistics method. Multivariate Cox regression analysis was used to examine the association between CDAI and mortality risks, and hazard ratios with 95% confidence intervals were calculated. Restricted cubic spline (RCS) curves were used to visualize the correlations. After analyzing data from 22,591 hypertensive adults, the optimal CDAI cut-off was found to be −1.23, categorizing participants into high and low CDAI groups. The results showed that the high CDAI group had a lower risk of cardiovascular and all-cause mortality (HR [95% CI]: 0.73 [0.61–0.87] and 0.79 [0.71–0.88], respectively). RCS analysis indicated a negative linear relationship with cardiovascular mortality and a nonlinear relationship with all-cause mortality. Subgroup and sensitivity analyses confirmed these findings. In conclusion, CDAI is a valuable predictor of long-term mortality risks in hypertensive individuals and can serve as a cost-effective tool for assessing their prognosis.


  • Open Access

    Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis

    by Mei Yang, Yanqing Wu, Xuemei Liu, Chen Zhao, Ting Li, Tingqian Li, Xiawei Zhang, Hongli Jiang, Bing Mao, Wei Liu


  • Open Access

    Myeleterosis in an ALPS5 patient with primary immune dysregulation syndrome

    by Hongyu Long, Zhao Chen, Bo Xiao, Beisha Tang, Hong Jiang